Contra Line
Gaming · Console Games
$63Mtotal raised · 4 rounds on record
$55.8Mlatest round · Venture round · May 2026 · 5 mo ago
9backers · RA Capital Management, Allied Venture Partners
$1.4Mgrants · 2 grants · CORDIS
Overview
Biotechnology company pioneering reversible male contraception. Our products, NES/T and ADAM, are daily and long-lasting options in clinical testing today.
Funding and backers
Total raised
$63M
4 rounds on record
Latest round
$55.8M
Venture round · May 2026 · 5 mo ago
Team
12
US Form 5500 (plan participants) · Dec 2025 · +9% in a year
Grants
$1.4M
2 grants · CORDIS
Backers
9
RA Capital Management, Allied Venture Partners
The money's age
Fresh money
5 months since the last round · not hiring
Momentum
20/100
fresh money
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
May 29
Raised a round Venture round $55.8M · SEC Form D
Sep 15, 2025
Won a grant $1.1M · CORDIS
Sep 10, 2024
Won a grant $291k · CORDIS
Mar 2, 2021
Raised a round Convertible Note $7.2M · SEC Form D
2017
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | May 2026 | $55.8M | — | SEC Form D |
| Grant | Sep 2025 | $1.1M | — | CORDIS |
| Grant | Sep 2024 | $291k | — | CORDIS |
| Convertible Note | Mar 2021 | $7.2M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Contraline, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Kevin EisenfratsExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
RA Capital Management 
GV 
Meta Planet 
VU Venture Partners Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Spekter Games is pioneering the next-gen gaming experience on Telegram and beyond.
VITURE XR glasses and accessories bring award-winning wearable displays to your entertainment, gaming, and productivity, anywhere you go.
Full-service UA for PC/Console: Steam retargeting, full-funnel attribution, faster optimization cycles. 3M+ wishlists, 3.2x ROAS. Book a…
Welcome to the official SQUARE ENIX website. Find all the latest news and updates about your favourite games and upcoming releases.
Sell your phone, laptop, tablet, camera or gaming console for cash. Instant quote, fair market value, free Pick-up, Drop-off or shipping in…
Flattering swimwear designed to fit you, not the other way around. Discover your sustainable swimwear soulmate now from 250+ designer…
People
Kevin Eisenfrats
Executive Officer, Director
Martin Emerson
Director
Gurdane Bhutani
Director
Tom Thorpe
Director
Michael King
Director
Iris Van Alderwerelt van Rosenburgh
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Amboy Street VenturesVia a fund
Cleo CapitalVia a fund
Lumira VenturesVia a fund
Charlottesville Angel NetworkVia a fund
Allied Venture PartnersVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Contraline Secures $92.5M to Push Its Male Birth Control Candidates Forward
Contraline raised $92.5 million in new funding to advance its two male contraceptive candidates, including a once-daily topical gel and an implantable option.
Read more
Report
Contraline secures $92.5m to push male contraceptive into late-stage trials
The Google Ventures-backed company could become the first to commercialise a reversible male contraceptive drug, provided the gel is successful in Phase III.
Read more
Report
Contraline Raises $92.5 Million Series B To Advance Male Contraceptive NES/T Gel Into Late-Stage Development
Contraline, a clinical-stage biopharmaceutical company developing novel male contraceptives, announced the closing of a $92.5 million Series B financing round. The financing was co-led by BVF Partners L.P. and RA Capital Management, with participation fro
Read more
Report
Contraline Announces $92.5 Million Series B Financing to Advance NES/T Male Contraceptive into Late-Stage Development
CHARLOTTESVILLE, Va., June 02, 2026--Contraline, Inc., a clinical-stage biopharmaceutical company developing novel male contraceptives, today announced the closing of a $92.5 million Series B financing co-led by BVF Partners L.P. and RA Capital Management
Read more
Report
A Gel Injected Into the Scrotum Could Be the Next Male Contraceptive
Biotech company Contraline has safely implanted a sperm-blocking hydrogel in 23 men. It's designed to be a fully reversible vasectomy.
Read more
Report
Contraline erects $7.2M for contraceptive implants for men
The ADAM Study is assessing the safety of the ADAM Hydrogel, while monitoring the semen parameters of the study subjects over three years.
Read more
Report
Report
Contraline Appoints Medical Device Industry Leader Dr. Yelena Tropsha as Chief Technology Officer
Contraline, Inc., a venture-backed medical device company devoted to providing men with long-lasting, safe, and effective contraception has appointed medical...
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Charlottesville
United States
HQ
Pipeline
200-500 est. staff
818 E. Jefferson St, Suite 201, Charlottesville, VA 22902